EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Survival Outcomes and Late Toxicity of Postoperative Radiotherapy in Patients With Adenoid Cystic Carcinoma of the External Auditory Canal

Li Wang iD, Xinmao Song, Zhenhu Li, Haojiong Zhang, Gang Yang, Tianci Tang, Lifen Zou, Zi-Wei Tu, Xiaoshen Wang iD

Cancer Medicine · 2026

DOI: 10.1002/cam4.71501 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Li Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Eye & ENT Hospital, Fudan University, Shanghai, People's Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Adenoid Cystic, Ear Canal, Ear Neoplasms. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of China, Fudan University Affiliated Jinshan Hospital youth Research Fund, the Excellent Young Scientists Fund of Jiangxi Cancer Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adenoid cystic carcinoma (ACC) of the external auditory canal (EAC) is an extremely rare head and neck malignancy. The study aimed to investigate the long‐term outcomes and late toxicity of postoperative radiotherapy (PORT) for patients with EAC ACC.

Methods

Between 2004 and 2021, 60 patients with EAC ACC were retrospectively analyzed. The overall survival (OS), local recurrence‐free survival (LRFS), nodal recurrence‐free survival (NRFS), and distant metastasis‐free survival (DMFS) were calculated by the Kaplan–Meier method.

Results

With a median follow‐up of 110.3 months, the 10‐year OS, LRFS, NRFS, and DMFS rates were 84.2%, 79.5%, 96.2%, and 59.9% after PORT, respectively. Eleven patients (18.3%) experienced local failure, 2 (3.3%) had regional failure, and 23 (38.3%) had distant metastasis (DM). Multivariate analysis showed that the advanced T stage (T3–4) was an independent risk factor for OS ( p = 0.019) and DMFS ( p = 0.006). Late toxicities were assessed in 45 patients. Among them, 73.3% (33/45) of patients experienced grade 3–4 ipsilateral hearing loss after surgery. Furthermore, xerostomia (31.1%, 14/45) and radiation‐related caries (26.7%, 12/45) were the most common late toxicities of radiotherapy‐related. For clinical N0 (cN0) patients ( n = 58), the ipsilateral elective neck irradiation (ENI) did not improve the OS ( p = 0.929), NRFS ( p = 0.317), or DMFS ( p = 0.778) for the advanced patients (T3–4).

Conclusions

Surgery plus PORT is associated with excellent long‐term survival with tolerable late toxicity for EAC ACC patients. ENI of cN0 patients shows no survival benefit, which suggests that the omission of ENI is reasonable to reduce radiation‐related toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Adenoid CysticEar CanalEar NeoplasmsHumansMaleFemaleMiddle AgedAgedRetrospective StudiesAdultRadiotherapy, AdjuvantTreatment OutcomeYoung AdultAged, 80 and overKaplan-Meier EstimateNeoplasm Recurrence, Local

Stichwörter der Autor:innen

adenoid cystic carcinoma (ACC)distant metastasisexternal auditory canallate toxicityradiotherapy

Autor:innen und Institutionen

  • Department of Radiation Oncology, Eye & ENT Hospital, Fudan University, Shanghai, People's Republic of China.
  • Department of Oncology, Jinshan Hospital, Fudan University, Shanghai, People's Republic of China.
  • Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, People's Republic of China.
  • NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, People's Republic of China.
  • Department of Radiation Oncology, Jiangxi Clinical Research Center for Cancer, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, People's Republic of China.

ORCID-Profile: Li Wang, Xiaoshen Wang

Förderung

  • Natural Science Foundation of China
  • Fudan University Affiliated Jinshan Hospital youth Research Fund
  • the Excellent Young Scientists Fund of Jiangxi Cancer Hospital
  • National Natural Science Foundation of China

Zitieren

APA

Wang, L., Song, X., Li, Z., Zhang, H., Yang, G., Tang, T., Zou, L., Tu, Z. W., & Wang, X. (2026). Survival Outcomes and Late Toxicity of Postoperative Radiotherapy in Patients With Adenoid Cystic Carcinoma of the External Auditory Canal. Cancer Medicine. https://doi.org/10.1002/cam4.71501

Vancouver

Wang L, Song X, Li Z, Zhang H, Yang G, Tang T, et al. Survival Outcomes and Late Toxicity of Postoperative Radiotherapy in Patients With Adenoid Cystic Carcinoma of the External Auditory Canal. Cancer Medicine. 2026. doi:10.1002/cam4.71501

BibTeX
@article{Wang2026,
  author = {Wang, Li and Song, Xinmao and Li, Zhenhu and Zhang, Haojiong and Yang, Gang and Tang, Tianci and Zou, Lifen and Tu, Zi-Wei and Wang, Xiaoshen},
  title = {Survival Outcomes and Late Toxicity of Postoperative Radiotherapy in Patients With Adenoid Cystic Carcinoma of the External Auditory Canal},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.71501}
}
Kostenlos starten →